1 |
Xin Q, Zhang S, Wang C, et al. Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018[J]. J Chin Med (Engl), 2023, 136 (5): 588-595.
|
2 |
Campbell-Quintero S, Echeverría LE, Gomez-Mesa JE, et al. Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: insights from the Colombian heart failure registry (RECOLFACA)[J]. Int J Cardiol, 2023, 378: 123-129.
|
3 |
王霞,丁劲,葸英博,等. 不同左室射血分数慢性心力衰竭病人运动康复的研究进展[J]. 全科护理,2023,21(31):4384-4387.
|
4 |
张清洋,朱业,顾翔. 慢性心力衰竭合并缺血性脑卒中患者的临床特点及危险因素研究[J]. 中华老年心脑血管病杂志,2024,26(9):1026-1030.
|
5 |
García-álvarez A, Blanco I, García-Lunar I, et al. β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial[J]. Eur J Heart Fail, 2023, 25 (3): 373-385.
|
6 |
Van Der Hoef CCS, Boorsma EM, Emmens JE, et al. Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome[J]. Eur J Heart Fail, 2023, 25 (2): 163-173.
|
7 |
Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44 (38): 3720-3826.
|
8 |
Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium[J]. Circulation, 2011, 123 (23): 2736-2747.
|
9 |
国家心血管病中心,国家心血管病专家委员会心力衰竭专业委员会,中国医师协会心力衰竭专业委员会,等. 国家心力衰竭指南2023[J]. 中华心力衰竭和心肌病杂志,2023,7(4):215-311.
|
10 |
李毅,韩雅玲. 2023 ESC急性冠脉综合征管理指南解读[J]. 中华心血管病杂志,2023,51(12):1263-1267.
|
11 |
Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021, 42 (14): 1289-1367.
|
12 |
蔡江萍,黄小金,董汉升,等. 非糖尿病患者甘油三酯葡萄糖指数和高敏C反应蛋白联合效应与脑扩大的血管周围间隙的相关性分析[J]. 福建医科大学学报,2023,57(5):347-354.
|
13 |
赵倩,王颖,谢依热·哈木拉提,等. 睡眠质量与心脑血管疾病发病中、低危人群颈动脉粥样硬化的相关性分析[J]. 上海交通大学学报(医学版),2023,43(11):1366-1373.
|
14 |
陶颖,吉小静,朱潇菲,等. 弹力带抗阻运动对维持性血液透析患者睡眠质量和疲乏状况的影响[J]. 中国临床护理,2024,16(10):604-608.
|
15 |
苏文刚,杨海洋,孙富强. 老年慢性心力衰竭患者心肌能量代谢改变及其与不良心血管事件的关联[J]. 中华老年心脑血管病杂志,2024,26(11):1296-1300.
|
16 |
Costabile G, Bergia RE, Vitale M, et al. Effects on cardiovascular risk factors of a low-vs high-glycemic index Mediterranean diet in high cardiometabolic risk individuals: the MEDGI-Carb study[J]. Eur J Clin Nutr, 2024, 78 (5): 384-390.
|
17 |
Zhang F, Kadierding R, Zhang S, et al. Triglyceride glucose index for predicting major adverse cardiovascular events in Chinese patients with hypertension[J]. Angiology, 2023, 74 (3): 259-267.
|
18 |
Echouffo-Tcheugui JB, Zhang S, McEvoy J, et al. In-sulin resistance and N-terminal pro-B-type natriuretic peptide among healthy adults[J]. JAMA Cardiol, 2023, 8 (10): 989-995.
|
19 |
Kite TA, Kurmani SA, Bountziouka V, et al. Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials[J]. Eur Heart J, 2022, 43 (33): 3148-3161.
|
20 |
Naganuma J, Sakuma M, Kitahara K, et al. Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia[J]. Hypert Res, 2023, 46 (3): 688-696.
|
21 |
张雅婧,田晶,韩港飞,等. 慢性心力衰竭患者报告结局变化影响因素分析[J]. 中国慢性病预防与控制,2023,31(6):406-410.
|
22 |
王蕾,董少元,原文龙,等. 吲哚布芬联合尼可地尔对高出血风险不稳定型心绞痛的疗效及安全性分析[J]. 中国药物应用与监测,2024,21(6):691-694.
|
23 |
陈红,阮骊韬,师桃,等. 右心室心肌应变与左心室辅助装置植入后早期右心衰竭的相关性研究[J/OL]. 中华危重症医学杂志(电子版),2024,17(1):26-31.
|
24 |
Dos Santos GG, Bachi ALL, Rangel SC, et al. Acute and chronic response of supervised band-elastic resistance exercise in systemic cytokines levels of bipolar disorders and schizophrenia individuals: a pilot study[J]. Behav Brain Res, 2025, 476: 115248.
|
25 |
宗敏,关晓楠,常晶,等. 衰弱对老年射血分数减低的心力衰竭患者的影响[J]. 中华老年心脑血管病杂志,2024,26(5):523-526.
|